How Wearables Help in Chronic Care Management

MedTech Outlook | Tuesday, October 20, 2020

To increase the demand for wearable technologies among chronic diseases, healthcare providers and payers must promote cardiovascular monitoring.

FREMONT, CA: Healthcare providers and payers are continuously searching for methods to increase the efficiency of the patient-generated health data with the help of consumer wearable adoption. The wearables can increase the range of userbase by identifying the population of chronic disease.

The consumer wearables develop useful data, but it might not help the healthcare providers how patient-generated health data (PGHD) can supplement provider and payer management strategies if it is from the wrong customer. Presently the PGHD pool is limited.

Usually, the PGHD is collected from patient wearables and remote patient monitoring devices. It provides several opportunities for medical providers and healthcare payers to track and control clinical trials. It is also incredibly helpful for diagnosing and detecting medical conditions, home patient monitoring, care management plans, managing clinical trials, chronic disease management.

Currently, the remote monitoring devices are underused because significantly fewer consumers use wearables. Wearable technologies are also not getting a better hold outside the low-risk populations. Most of the patients who utilize wearables are either athletes or suffers from chronic disease. The wealthy consumers also increasingly using wearable than low-income consumers. For the healthcare providers and payers, this narrow user base is not helpful because they want to utilize PGHD for increasing the growth of care management and chronic disease prevention.

The present wearables used can prevent some of the consumers in the low-risk population from moving into rising players. The payers and providers will also have to work more to increase the user base to gather more actionable information. It will also play a significant role in the way payers and providers promote these technologies to the patients will chronic illness. The primary reason for this is the increasing demand for consumer wearable technology.

See also: Top Immunotherapy Companies